Aminosalicylate

Assets acting on this target.

Class
Aminosalicylate
Notes
openFDA EPC fill 2026-08-24 (exact-name label match: Sulfasalazine); source: https://api.fda.gov/drug/label.json?search=openfda.generic_name%3A%22Sulfasalazine%22+openfda.brand_name%3A%22Sulfasalazine%22&limit=12

By indication

Aminosalicylate drugs compared

9 drugs, stage by indication
9 drugs acting on Aminosalicylate: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
balsalazide disodium (Colazal)ColazalBausch Healthsmall moleculeApprovedApproved in Ulcerative Colitis
mesalamine (Apriso)AprisoBausch Healthsmall moleculeApprovedApproved in Ulcerative Colitis
Mesalamine (Canasa)CanasaAbbViesmall moleculeApprovedApproved in Ulcerative Colitis
Mesalamine (Lialda)LialdaCosmo N.V., Takeda Pharmaceutical Companysmall moleculeApprovedApproved in Ulcerative Colitis
Mesalamine (Pentasa)PentasaFerring Pharmaceuticals, Takeda Pharmaceutical Companysmall moleculeApprovedApproved in Ulcerative Colitis
mesalamine (Rowasa)RowasaViatrissmall moleculeApprovedApproved in Ulcerative Colitis
olsalazine (Dipentum)DipentumViatrissmall moleculeApprovedApproved in Ulcerative Colitis
SulfasalazinePfizersmall moleculeApprovedApproved in Rheumatoid Arthritis; Approved in Ulcerative Colitis
mesalamine (Asacol HD)Asacol HDAbbViesmall moleculeUS approval withdrawnUS approval withdrawn in Ulcerative Colitis

← all mechanisms